AstraZeneca To Divest Medical Devices Division

BMI View: Drugmakers targeting a wide range of therapeutic areas and diversifying their product range will significantly enhance their long-term growth opportunities. Moreover, by expanding their presence in a wide range of international markets, firms will reduce long-term risks associated with a particular market i.e. pricing pressures, and will maximise their chances of profiting from rapid revenue growth in less obvious emerging markets.

To read the full article, please choose one of the following options: